Latvia might get fewer AstraZeneca vaccines in Q1

Health Minister Daniels Pavļuts said at a press briefing January 25 that Latvia might receive fewer AstraZeneca vaccines in first quarter than  planned.

Pavļuts said that the delay is related to insufficient production volumes. Citing unofficial sources, Pavļuts said that Latvia  might only get 110 000 instead of 424 000 AstraZeneca vaccines in the first three months. 

Health Minister said that it would significantly slow down the possibilities to begin mass vaccination in March. 

The issue, Pavļuts said, affects all countries buying vaccines from this producer.

Foreign Minister Edgars Rinkēvičs told Latvian Radio January 26 that it is possible Latvia would press charges and take the matter to court. "We think it is unfair that obligations are not being fulfilled, especially AstraZeneca, who has received significant funding from the European Union," said Rinkēvičs.

Seen a mistake?

Select text and press Ctrl+Enter to send a suggested correction to the editor

Select text and press Report a mistake to send a suggested correction to the editor

Related articles
Most read

Please be aware that the LSM portal uses cookies. By continuing to use this site, you agree that we may store and use cookies on your device. Find out more

Accept and continue